300942 易瑞生物
按盤價 
10.980 -0.730 (-6.234%)
10.980 -0.730 (-6.234%) | 2025/06 - 中期 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 0.270 | 1.993 | -20.388 | 8.689 | 31.665 |
| 總資產報酬率 ROA (%) | 0.163 | 1.217 | -14.015 | 6.814 | 26.200 |
| 投入資產回報率 ROIC (%) | 0.174 | 1.316 | -15.477 | 7.659 | 29.590 | 邊際利潤分析 |
| 銷售毛利率 (%) | 64.466 | 70.628 | 49.929 | 56.506 | 71.632 |
| 營業利潤率 (%) | 0.421 | 9.349 | -68.987 | 14.283 | 44.897 |
| 息稅前利潤/營業總收入 (%) | 2.860 | 12.285 | -71.069 | 12.577 | 45.693 |
| 淨利潤/營業總收入 (%) | 1.729 | 7.411 | -72.798 | 12.034 | 39.574 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | -105.145 | 70.945 | 44.059 | 138.511 | 92.300 |
| 價值變動淨收益/利潤總額(%) | -95.801 | -20.205 | 30.419 | 2.820 | 3.606 |
| 營業外收支淨額/利潤總額(%) | 28.698 | -6.480 | 1.404 | -3.395 | -0.089 | 償債能力分析 |
| 流動比率 (X) | 6.414 | 4.946 | 5.387 | 3.376 | 5.731 |
| 速動比率 (X) | 5.933 | 4.680 | 5.158 | 2.872 | 5.132 |
| 資產負債率 (%) | 39.062 | 40.278 | 37.425 | 24.777 | 17.869 |
| 帶息債務/全部投入資本 (%) | 34.569 | 35.666 | 29.327 | 10.962 | 1.914 |
| 股東權益/帶息債務 (%) | 187.645 | 178.619 | 234.117 | 763.464 | 4,870.858 |
| 股東權益/負債合計 (%) | 155.821 | 148.061 | 167.253 | 303.659 | 458.756 |
| 利息保障倍數 (X) | 1.260 | 3.505 | 64.635 | -10.167 | 54.695 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 151.517 | 136.622 | 113.357 | 47.412 | 48.002 |
| 存貨周轉天數 (天) | 215.857 | 196.462 | 186.842 | 117.164 | 165.069 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 09/09/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
